Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: a randomized controlled trial [ISRCTN25438351]
Open Access
- 31 October 2007
- journal article
- research article
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 7 (1) , 34
- https://doi.org/10.1186/1472-6882-7-34
Abstract
The efficacy and safety of a dietary supplement derived from South American botanicals was compared to glucosamine sulfate in osteoarthritis subjects in a Mumbai-based multi-center, randomized, double-blind study.Keywords
This publication has 67 references indexed in Scilit:
- Glucosamine for pain in osteoarthritis: Why do trial results differ?Arthritis & Rheumatism, 2007
- Effects of oral glucosamine sulphate on serum glucose and insulin during an oral glucose tolerance test of subjects with osteoarthritisAnnals of the Rheumatic Diseases, 2007
- Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort studyRheumatology, 2007
- Oral Glucosamine for 6 Weeks at Standard Doses Does Not Cause or Worsen Insulin Resistance or Endothelial Dysfunction in Lean or Obese SubjectsDiabetes, 2006
- An update on osteoarthritis therapeuticsCurrent Opinion in Rheumatology, 2006
- Glucosamine therapy for treating osteoarthritisCochrane Database of Systematic Reviews, 2005
- Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control studyThe Lancet, 2005
- Dual transduction of insulin‐like growth factor‐I and interleukin‐l receptor antagonist protein controls cartilage degradation in an osteoarthritic culture modelJournal of Orthopaedic Research, 2005
- Effect of Lepidium meyenii (MACA) on sexual desire and its absent relationship with serum testosterone levels in adult healthy menAndrologia, 2002
- Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-κB) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytesPublished by Elsevier ,2002